Sign In
Search Icon
Menu Icon

​​​REGEN-COV

Important Information About REGEN-COV

Due to the high frequency of the Omicron variant, REGEN-COV (casirivimab and imdevimab) is not currently authorized in any U.S. region. Therefore, REGEN-COV may not be administered for treatment or post-exposure prevention of COVID-19 under the Emergency Use Authorization until further notice by the FDA​.

REGEN-COV FDA EUA Resources


​​​​​